Xerecept Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Xerecept General Information
Description
A steroid used to reduce brain swelling associated with tumors. Xerecept owned by Neurobiological Tech is used on pediatric patients who are dependent on the steroid Decadron (dexamethasone) to treat peritumoral brain edema associated with cerebral tumors
Contact Information
Corporate Office
- 2000 Powell Street
- Suite 800
- Emeryville, CA 94608
- United States
Corporate Office
- 2000 Powell Street
- Suite 800
- Emeryville, CA 94608
- United States
Xerecept Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Xerecept Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Xerecept Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Xerecept FAQs
-
When was Xerecept founded?
Xerecept was founded in 2004.
-
Where is Xerecept headquartered?
Xerecept is headquartered in Emeryville, CA.
-
What industry is Xerecept in?
Xerecept’s primary industry is Drug Discovery.
-
Is Xerecept a private or public company?
Xerecept is a Private company.
-
What is Xerecept’s current revenue?
The current revenue for Xerecept is .
-
Who are Xerecept’s investors?
Celtic Pharmaceutical and Neurobiological Technologies have invested in Xerecept.
-
When was Xerecept acquired?
Xerecept was acquired on 01-Dec-2015.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
